Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?

by Enrica Teresa Tanda, Enrica Teresa Tanda, Elena Croce, Francesco Spagnolo, Lodovica Zullo, Stefano Spinaci, Carlo Genova, Carlo Genova, Giovanni Rossi, Giovanni Rossi
Published 2021-09-01

Metabolic Parameters as Biomarkers of Response to Immunotherapy and Prognosis in Non-Small Cell Lung Cancer (NSCLC): A Real World Experience

by Lavinia Monaco, Maria Gemelli, Irene Gotuzzo, Matteo Bauckneht, Cinzia Crivellaro, Carlo Genova, Diego Cortinovis, Lodovica Zullo, Luca Carlofrancesco Ammoni, Davide Paolo Bernasconi, Giovanni Rossi, Silvia Morbelli, Luca Guerra
Published 2021-04-01

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer

by Sara Elena Rebuzzi, Lodovica Zullo, Giovanni Rossi, Massimiliano Grassi, Veronica Murianni, Marco Tagliamento, Arsela Prelaj, Simona Coco, Luca Longo, Maria Giovanna Dal Bello, Angela Alama, Chiara Dellepiane, Elisa Bennicelli, Umberto Malapelle, Carlo Genova
Published 2021-03-01

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient

by Giovanni Rossi, Alessandro Russo, Marco Tagliamento, Alessandro Tuzi, Olga Nigro, Giacomo Vallome, Claudio Sini, Massimiliano Grassi, Maria Giovanna Dal Bello, Simona Coco, Luca Longo, Lodovica Zullo, Enrica Teresa Tanda, Chiara Dellepiane, Paolo Pronzato, Carlo Genova
Published 2020-04-01

The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab

by Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli
Published 2021-06-01